Particle.news
Download on the App Store

Common Antibiotic Tied to Lower Schizophrenia Risk in Adolescent Psychiatric Patients

The Finnish registry study published in the American Journal of Psychiatry reports an association that requires randomized trials before any preventive use.

Overview

  • Researchers analyzed Finnish nationwide health registers for more than 56,000 people who used adolescent psychiatric services and received antibiotics, comparing doxycycline users with peers given other antibiotics.
  • Doxycycline exposure was associated with a roughly 30–35% lower 10-year risk of schizophrenia relative to other antibiotics in this high-risk group.
  • Absolute risks were about 2.1% for non-doxycycline antibiotic users versus 1.4–1.5% for those prescribed doxycycline, estimated with an emulated target-trial approach.
  • The signal appeared specific to schizophrenia and did not extend to broader non-affective psychoses in the study’s analyses.
  • Authors emphasize the observational design, prescription-record limitations and potential residual confounding, and they call for randomized clinical trials and mechanistic studies.